PUBLISHER: Market Xcel - Markets and Data | PRODUCT CODE: 1422062
PUBLISHER: Market Xcel - Markets and Data | PRODUCT CODE: 1422062
Cell Therapy Market Assessment, By Therapy Type, By Cell Type, By Product, By Application, By End-users, By Region, Opportunities and Forecast, 2017-2031F
Global cell therapy market size was valued at USD 4.67 billion in 2023, expected to reach USD 12.93 billion in 2031, with a CAGR of 13.56% for the forecast period between 2024 and 2031. Several factors propel the global cell therapy market, creating an exciting and high-potential environment. Key drivers include the rising prevalence of chronic diseases, increasing investments in research and development, continuous advancements in cell therapy technologies, a supportive regulatory environment, collaborative partnerships, and growing applications. A prominent force behind the growing demand is the increasing prevalence of chronic diseases worldwide. As these conditions become more prevalent, there is an increasing demand for innovative and effective treatments, positioning cell therapy as a promising solution.
Pharmaceutical companies and research institutions are investing significant amounts in exploring the vast potential of cell therapies. This financial commitment fosters groundbreaking discoveries and accelerates the development of novel treatments. Advancements in cell therapy technologies are further contributing to this dynamic landscape. Breakthrough technologies such as CRISPR gene editing are enhancing the precision and efficacy of cell therapies, opening new possibilities for therapeutic interventions across various medical domains in global cell therapy market. A supportive regulatory environment acts as a catalyst, streamlining approval processes and encouraging companies to invest in the development of cell-based treatments, boosting the growth of the global cell therapy market. Collaborative partnerships between pharmaceutical/biotech firms, and academic institutions leverage collective strengths, fostering innovation and expediting the commercialization of promising therapies. As cell therapy applications continue to broaden from oncology to neurodegenerative diseases, the global awareness and acceptance of these innovative treatments are on the rise.
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant catalyst for the global cell therapy market. As the population aged 50 and above faces a staggering increase in the incidence of at least one chronic disease, the numbers are projected to surge by 99.5%, reaching 142.66 million by 2050 from 71.522 million in 2020. The demographic shift signifies an urgent need for advanced and effective therapeutic interventions, with cell therapy emerging as a promising solution. Moreover, the projection of a 91.16% increase in individuals with multimorbidity-from 7.8304 million in 2020 to 14.968 million in 2050, highlights the complexity of health challenges an aging population faces. In response to the growing health burden, the demand for innovative cell therapies is rising, positioning the market to address the evolving healthcare landscape and offer targeted solutions for chronic disease management.
Growing Investments for Developing Modern Cell Therapy Solutions
Leading companies are investing substantially in cell therapy by establishing state-of-the-art manufacturing facilities. The initiative reflects their confidence in cell therapies' potential and is a significant driver for the global cell therapy market. Significant investments in advanced production facilities enable increasing production capacity and scalability, resulting in a more efficient and widespread delivery of cell-based treatments. The proactive approach by major industry players fosters innovation and contributes to the overall growth and maturity of the global cell therapy market, solidifying their position as a transformative force in healthcare.
For instance, in October 2023, Bayer AG revealed its inaugural cell therapy launch facility in Berkeley, California, marking a pivotal step in their global initiative to provide cell therapies to patients. The USD 250 million, 100,000-square-foot facility is designed to meet the demand for materials in late-stage clinical trials and the potential commercial launch of BlueRock Therapeutics' bemdaneprocel (BRT-DA01), an investigational cell therapy under assessment for Parkinson's disease treatment. The establishment of the cutting-edge facility underscores Bayer's commitment to advancing cell therapies on a global scale and signifies a significant investment in the future of innovative medical solutions.
Government Initiatives
Governments around the globe are collaborating with major companies to stimulate the growth of the global cell therapy market. These partnerships aim to leverage governmental support and expertise to advance research, development, and accessibility of cell therapies. By fostering such collaborations, policymakers seek to create a conducive environment for innovation, accelerate regulatory approvals, and ensure widespread adoption of these advanced medical interventions. The synergy between governments and key industry players reflects a shared commitment to realize the full potential of cell therapies in revolutionizing healthcare and addressing challenges on a global scale.
In September 2023, the United States government unveiled new measures as part of the Cancer Moonshot Initiative, a focal point in the battle against cancer. The initiative was led by President through the collaborative entity "CancerX," aiming to reduce the U.S. cancer death rate by 50% before 2047. The initiative includes prominent pharmaceutical companies and their partnership with digital healthcare solution providers such as Amazon and Intel. The Moffitt Cancer Center in Florida and the Digital Medicine Society (DiMe), a global non-profit of digital medicine experts, lead the effort.
Growing Demand for T-Cell Therapy
The global cell therapy market is witnessing a growing demand for T-cell therapy. The innovative approach has gained prominence due to its remarkable success in treating certain cancers, especially hematologic malignancies. As clinical trials demonstrate its efficacy and safety, the demand for T-cell therapy is increasing. Patients, healthcare providers, and pharmaceutical companies recognize its potential to revolutionize cancer treatment by leveraging the body's immune system. The increasing demand is propelling research, development, and investment in T-cell therapies, contributing to the dynamic growth of global cell therapy market.
In March 2023, Thermo Fisher Scientific and Arsenal Biosciences, Inc., American companies, announced their strategic partnership to advance the manufacturing processes for novel cancer treatments. The collaboration emphasizes research and process development to establish a robust manufacturing framework for their cutting-edge, programmable autologous T cells designed for cancer treatment.
Future Market Scenario
The global cell therapy market is poised for a promising future, driven by a convergence of factors highlighting its potential to revolutionize healthcare. Advancements in cell therapy technologies, including precision-enhancing techniques like CRISPR gene editing, are increasing the efficacy and scope of treatments. The rising prevalence of chronic diseases, such as cancer and autoimmune disorders, create a compelling need for innovative therapeutic solutions, positioning cell therapy at the forefront of medical breakthroughs. Collaborative partnerships between pharmaceutical companies, biotech firms, and academic institutions are accelerating research and development efforts, fostering a dynamic environment of innovation. Supportive regulatory frameworks and increasing stakeholder awareness contribute towards a favorable landscape for the market's growth. With expanding applications across diverse medical domains and a global commitment to addressing unmet healthcare needs, the cell therapy market is poised to play a pivotal role in shaping the future of healthcare.
Key Players Landscape and Outlook
Numerous major companies are actively forming collaborations in the global cell therapy market. These strategic partnerships facilitate the pooling of resources, expertise, and technologies to drive innovation and expedite the development of advanced cell-based therapies. By joining forces, these companies enhance their capabilities in research, clinical trials, and manufacturing processes, ultimately contributing to the evolution and expansion of the cell therapy market.
For instance, in August 2023, Astellas Pharma Inc. and Poseida Therapeutics, Inc. unveiled a strategic investment to bolster Poseida's pioneering efforts in redefining cancer cell therapy. In the financial arrangement, Astellas is set to invest a total of USD 50 million, comprising a USD 25 million acquisition of 8,333,333 shares of Poseida's common stock (representing around 8.8% of the total outstanding common stock) at USD 3.00 per share through a private placement. Additionally, a one-time payment of USD 25 million secures Astellas an exclusive negotiation and first refusal right to license Poseida's clinical stage program, P-MUC1C-ALLO1. The program involves the development of an allogeneic CAR-T cell therapy targeting multiple solid tumor indications.
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Executive Summary
4. Global Cell Therapy Market Outlook, 2017-2031F
- 4.1. Market Size & Forecast
- 4.1.1. Value
- 4.1.2. Volume
- 4.2. By Therapy Types
- 4.2.1. Allogenic Therapies
- 4.2.2. Autologous Therapies
- 4.3. By Cell Type
- 4.3.1. Stem Cell
- 4.3.2. Non-Stem Cell
- 4.4. By Product
- 4.4.1. Media, Sera, and Reagents
- 4.4.2. Cell Engineering Products
- 4.4.3. Cell Culture Vessels
- 4.4.4. Cell Therapy Equipment
- 4.4.5. System and Software
- 4.4.6. Other Products
- 4.5. By Application
- 4.5.1. Cardiovascular
- 4.5.2. Musculoskeletal
- 4.5.3. Oncology
- 4.5.4. Dermatology
- 4.5.5. Others
- 4.6. By End-users
- 4.6.1. Hospitals and Clinics
- 4.6.2. Biopharmaceutical and Biotech Companies
- 4.6.3. Academic and Research Institutes
- 4.6.4. Others
- 4.7. By Region
- 4.7.1. North America
- 4.7.2. Europe
- 4.7.3. South America
- 4.7.4. Asia-Pacific
- 4.7.5. Middle East and Africa
- 4.8. By Company Market Share (%), 2023
5. Global Cell Therapy Market Outlook, By Region, 2017-2031F
- 5.1. North America*
- 5.1.1. Market Size & Forecast
- 5.1.1.1. Value
- 5.1.1.2. Volume
- 5.1.2. By Therapy Types
- 5.1.2.1. Allogenic Therapies
- 5.1.2.2. Autologous Therapies
- 5.1.3. By Cell Type
- 5.1.3.1. Stem Cell
- 5.1.3.2. Non-Stem Cell
- 5.1.4. By Product
- 5.1.4.1. Media, Sera, and Reagents
- 5.1.4.2. Cell Engineering Products
- 5.1.4.3. Cell Culture Vessels
- 5.1.4.4. Cell Therapy Equipment
- 5.1.4.5. System and Software
- 5.1.4.6. Other Products
- 5.1.5. By Application
- 5.1.5.1. Cardiovascular
- 5.1.5.2. Musculoskeletal
- 5.1.5.3. Oncology
- 5.1.5.4. Dermatology
- 5.1.5.5. Others
- 5.1.6. By End-users
- 5.1.6.1. Hospitals and Clinics
- 5.1.6.2. Biopharmaceutical and Biotech Companies
- 5.1.6.3. Academic and Research Institutes
- 5.1.6.4. Others
- 5.1.7. United States*
- 5.1.7.1. Market Size & Forecast
- 5.1.7.1.1. Value
- 5.1.7.1.2. Volume
- 5.1.7.2. By Therapy Types
- 5.1.7.2.1. Allogenic Therapies
- 5.1.7.2.2. Autologous Therapies
- 5.1.7.3. By Cell Type
- 5.1.7.3.1. Stem Cell
- 5.1.7.3.2. Non-Stem Cell
- 5.1.7.4. By Product
- 5.1.7.4.1. Media, Sera, and Reagents
- 5.1.7.4.2. Cell Engineering Products
- 5.1.7.4.3. Cell Culture Vessels
- 5.1.7.4.4. Cell Therapy Equipment
- 5.1.7.4.5. System and Software
- 5.1.7.4.6. Other Products
- 5.1.7.5. By Application
- 5.1.7.5.1. Cardiovascular
- 5.1.7.5.2. Musculoskeletal
- 5.1.7.5.3. Oncology
- 5.1.7.5.4. Dermatology
- 5.1.7.5.5. Others
- 5.1.7.6. By End-users
- 5.1.7.6.1. Hospitals and Clinics
- 5.1.7.6.2. Biopharmaceutical and Biotech Companies
- 5.1.7.6.3. Academic and Research Institutes
- 5.1.7.6.4. Others
- 5.1.8. Canada
- 5.1.9. Mexico
- 5.1.1. Market Size & Forecast
All segments will be provided for all regions and countries covered:
- 5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
- 5.3. South America
- 5.3.1. Brazil
- 5.3.2. Argentina
- 5.4. Asia-Pacific
- 5.4.1. India
- 5.4.2. China
- 5.4.3. Japan
- 5.4.4. Australia
- 5.4.5. Vietnam
- 5.4.6. South Korea
- 5.4.7. Indonesia
- 5.4.8. Philippines
- 5.5. Middle East & Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa
6. Market Mapping, 2023
- 6.1. By Therapy Type
- 6.2. By Cell Type
- 6.3. By Product
- 6.4. By Application
- 6.5. By End-users
- 6.6. By Region
7. Macro Environment and Industry Structure
- 7.1. Supply Demand Analysis
- 7.2. Import Export Analysis
- 7.3. Value Chain Analysis
- 7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
- 7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat from New Entrant
- 7.5.5. Competitive Rivalry
8. Market Dynamics
- 8.1. Growth Drivers
- 8.2. Growth Inhibitors (Challenges and Restraints)
9. Regulatory Framework and Innovation
- 9.1. Clinical Trials
- 9.2. Patent Landscape
- 9.3. Regulatory Approvals
- 9.4. Innovations/Emerging Technologies
10. Key Players Landscape
- 10.1. Competition Matrix of Top Five Market Leaders
- 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
- 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
- 10.4. SWOT Analysis (For Five Market Players)
- 10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
- 13.1. Thermo Fisher Scientific Inc.
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products & Services
- 13.1.4. Financials (As reported)
- 13.1.5. Key Market Focus & Geographical Presence
- 13.1.6. Recent Developments
- 13.2. Merck KGaA
- 13.3. AstraZeneca plc
- 13.4. Astellas Pharma Inc.
- 13.5. Danaher Corporation
- 13.6. Sanofi S.A.
- 13.7. Becton, Dickinson and Company
- 13.8. Lonza Group
- 13.9. Novartis AG
- 13.10. Fresenius Medical Care AG & Co. KGaA
- 13.11. Avantor, Inc.
- 13.12. Bio-Techne Corporation
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.
14. Strategic Recommendations
15. About Us & Disclaimer
List of Tables
- Table 1. Pricing Analysis of Products from Key Players
- Table 2. Competition Matrix of Top 5 Market Leaders
- Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
- Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
List of Figures
- Figure 1. Global Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 2. Global Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 3. Global Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 4. Global Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 5. Global Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 6. Global Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 7. Global Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 8. Global Cell Therapy Market Share (%), By Region, 2017-2031F
- Figure 9. North America Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 10. North America Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 11. North America Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 12. North America Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 13. North America Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 14. North America Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 15. North America Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 16. North America Cell Therapy Market Share (%), By Country, 2017-2031F
- Figure 17. United States Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 18. United States Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 19. United States Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 20. United States Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 21. United States Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 22. United States Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 23. United States Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 24. Canada Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 25. Canada Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 26. Canada Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 27. Canada Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 28. Canada Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 29. Canada Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 30. Canada Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 31. Mexico Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 32. Mexico Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 33. Mexico Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 34. Mexico Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 35. Mexico Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 36. Mexico Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 37. Mexico Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 38. Europe Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 39. Europe Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 40. Europe Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 41. Europe Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 42. Europe Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 43. Europe Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 44. Europe Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 45. Europe Cell Therapy Market Share (%), By Country, 2017-2031F
- Figure 46. Germany Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 47. Germany Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 48. Germany Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 49. Germany Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 50. Germany Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 51. Germany Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 52. Germany Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 53. France Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 54. France Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 55. France Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 56. France Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 57. France Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 58. France Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 59. France Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 60. Italy Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 61. Italy Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 62. Italy Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 63. Italy Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 64. Italy Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 65. Italy Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 66. Italy Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 67. United Kingdom Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 68. United Kingdom Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 69. United Kingdom Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 70. United Kingdom Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 71. United Kingdom Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 72. United Kingdom Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 73. United Kingdom Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 74. Russia Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 75. Russia Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 76. Russia Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 77. Russia Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 78. Russia Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 79. Russia Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 80. Russia Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 81. Netherlands Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 82. Netherlands Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 83. Netherlands Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 84. Netherlands Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 85. Netherlands Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 86. Netherlands Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 87. Netherlands Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 88. Spain Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 89. Spain Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 90. Spain Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 91. Spain Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 92. Spain Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 93. Spain Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 94. Spain Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 95. Turkey Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 96. Turkey Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 97. Turkey Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 98. Turkey Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 99. Turkey Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 100. Turkey Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 101. Turkey Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 102. Poland Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 103. Poland Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 104. Poland Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 105. Poland Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 106. Poland Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 107. Poland Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 108. Poland Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 109. South America Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 110. South America Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 111. South America Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 112. South America Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 113. South America Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 114. South America Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 115. South America Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 116. South America Cell Therapy Market Share (%), By Country, 2017-2031F
- Figure 117. Brazil Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 118. Brazil Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 119. Brazil Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 120. Brazil Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 121. Brazil Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 122. Brazil Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 123. Brazil Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 124. Argentina Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 125. Argentina Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 126. Argentina Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 127. Argentina Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 128. Argentina Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 129. Argentina Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 130. Argentina Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 131. Asia-Pacific Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 132. Asia-Pacific Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 133. Asia-Pacific Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 134. Asia-Pacific Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 135. Asia-Pacific Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 136. Asia-Pacific Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 137. Asia- Pacific Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 138. Asia-Pacific Cell Therapy Market Share (%), By Country, 2017-2031F
- Figure 139. India Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 140. India Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 141. India Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 142. India Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 143. India Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 144. India Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 145. India Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 146. China Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 147. China Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 148. China Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 149. China Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 150. China Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 151. China Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 152. China Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 153. Japan Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 154. Japan Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 155. Japan Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 156. Japan Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 157. Japan Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 158. Japan Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 159. Japan Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 160. Australia Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 161. Australia Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 162. Australia Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 163. Australia Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 164. Australia Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 165. Australia Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 166. Australia Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 167. Vietnam Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 168. Vietnam Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 169. Vietnam Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 170. Vietnam Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 171. Vietnam Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 172. Vietnam Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 173. Vietnam Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 174. South Korea Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 175. South Korea Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 176. South Korea Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 177. South Korea Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 178. South Korea Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 179. South Korea Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 180. South Korea Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 181. Indonesia Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 182. Indonesia Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 183. Indonesia Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 184. Indonesia Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 185. Indonesia Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 186. Indonesia Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 187. Indonesia Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 188. Philippines Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 189. Philippines Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 190. Philippines Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 191. Philippines Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 192. Philippines Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 193. Philippines Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 194. Philippines Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 195. Middle East & Africa Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 196. Middle East & Africa Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 197. Middle East & Africa Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 198. Middle East & Africa Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 199. Middle East & Africa Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 200. Middle East & Africa Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 201. Middle East & Africa Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 202. Middle East & Africa Cell Therapy Market Share (%), By Country, 2017-2031F
- Figure 203. Saudi Arabia Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 204. Saudi Arabia Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 205. Saudi Arabia Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 206. Saudi Arabia Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 207. Saudi Arabia Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 208. Saudi Arabia Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 209. Saudi Arabia Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 210. UAE Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 211. UAE Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 212. UAE Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 213. UAE Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 214. UAE Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 215. UAE Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 216. UAE Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 217. South Africa Cell Therapy Market, By Value, In USD Billion, 2017-2031F
- Figure 218. South Africa Cell Therapy Market, By Volume, In Million Units, 2017-2031F
- Figure 219. South Africa Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
- Figure 220. South Africa Cell Therapy Market Share (%), By Cell Type, 2017-2031F
- Figure 221. South Africa Cell Therapy Market Share (%), By Product, 2017-2031F
- Figure 222. South Africa Cell Therapy Market Share (%), By Application, 2017-2031F
- Figure 223. South Africa Cell Therapy Market Share (%), By End-users, 2017-2031F
- Figure 224. By Therapy Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
- Figure 225. By Cell Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
- Figure 226. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
- Figure 227. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
- Figure 228. By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023
- Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
